Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
2628.HK Stock Summary
Top 10 Correlated ETFs
2628.HK
In the News
2628.HK Financial details
Company Rating
Sell
Market Cap
728.11B
Income
7.71B
Revenue
1072.97B
Book val./share
15.35
Cash/share
76.52
Dividend
0.53
Dividend %
5.98%
Employees
102.24K
Optionable
No
Shortable
Yes
Earnings
22 Aug 2024
P/E
29.46
Forward P/E
5.43
PEG
-4.55
P/S
0.57
P/B
0.52
P/C
0.12
P/FCF
2.03
Quick Ratio
32.32
Current Ratio
32.32
Debt / Equity
0.03
LT Debt / Equity
0.03
-
-
EPS (TTM)
0.63
EPS next Y
1.73
EPS next Q
-
EPS this Y
-36.67%
EPS next Y
172.13%
EPS next 5Y
326.67%
EPS last 5Y
23.3%
Revenue last 5Y
5.08%
Revenue Q/Q
641.33%
EPS Q/Q
-322.58%
-
-
-
-
SMA20
-10%
SMA50
-
SMA100
-18.18%
Inst Own
0%
Inst Trans
0%
ROA
-
ROE
2%
ROC
-
Gross Margin
100%
Oper. Margin
2%
Profit Margin
1%
Payout
399%
Shs Outstand
74.6B
Shs Float
74.6B
-
-
-
-
Target Price
-
52W Range
8.19-15.84
52W High
-37.4%
52W Low
+17.38%
RSI
50
Rel Volume
2.36
Avg Volume
30.44M
Volume
71.7M
Perf Week
-3.2%
Perf Month
-0.84%
Perf Quarter
-20.15%
Perf Half Y
-21.49%
-
-
-
-
Beta
0.825
-
-
Volatility
0.19%, 0.32%
Prev Close
0%
Price
9.39
Change
5.39%
2628.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 22.2 | 25.81 | 28.48 | 29.24 | 28.57 | |
Net income per share | 0.4 | 2.06 | 1.78 | 1.8 | 1.14 | |
Operating cash flow per share | 5.22 | 10.12 | 10.76 | 10.16 | 12.51 | |
Free cash flow per share | 4.53 | 9.72 | 10.49 | 9.96 | 12.4 | |
Cash per share | 32.6 | 39.35 | 45.01 | 52.82 | 66.3 | |
Book value per share | 11.26 | 14.29 | 15.92 | 16.97 | 15.5 | |
Tangible book value per share | 11.16 | 14.21 | 15.88 | 16.97 | 15.53 | |
Share holders equity per share | 11.26 | 14.29 | 15.92 | 16.97 | 15.5 | |
Interest debt per share | 0.86 | 2.25 | 2.21 | 2.23 | 1.93 | |
Market cap | 412.71B | 546.39B | 407.19B | 297.39B | 333.02B | |
Enterprise value | 382.05B | 551.21B | 407.78B | 292.82B | 254.77B | |
P/E ratio | 36.22 | 9.37 | 8.1 | 5.86 | 10.38 | |
Price to sales ratio | 0.66 | 0.75 | 0.51 | 0.36 | 0.41 | |
POCF ratio | 2.8 | 1.91 | 1.34 | 1.04 | 0.95 | |
PFCF ratio | 3.22 | 1.99 | 1.37 | 1.06 | 0.95 | |
P/B Ratio | 1.3 | 1.35 | 0.9 | 0.62 | 0.76 | |
PTB ratio | 1.3 | 1.35 | 0.9 | 0.62 | 0.76 | |
EV to sales | 0.61 | 0.76 | 0.51 | 0.36 | 0.32 | |
Enterprise value over EBITDA | 18.98 | 9.98 | 8.29 | 6.61 | 7.77 | |
EV to operating cash flow | 2.59 | 1.93 | 1.34 | 1.02 | 0.72 | |
EV to free cash flow | 2.98 | 2.01 | 1.38 | 1.04 | 0.73 | |
Earnings yield | 0.03 | 0.11 | 0.12 | 0.17 | 0.1 | |
Free cash flow yield | 0.31 | 0.5 | 0.73 | 0.94 | 1.05 | |
Debt to equity | 0.06 | 0.15 | 0.13 | 0.12 | 0.11 | |
Debt to assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | -1.52 | 0.09 | 0.01 | -0.1 | -2.39 | |
Current ratio | 17.31 | 19.4 | 20.89 | 26.58 | 31 | |
Interest coverage | 4.25 | 11.96 | 11.76 | 6.97 | 5.65 | |
Income quality | 10.6 | 4.78 | 5.58 | 5.67 | 14.64 | |
Dividend Yield | 0.03 | 0.01 | 0.05 | 0.06 | 0.06 | |
Payout ratio | 1.03 | 0.08 | 0.41 | 0.36 | 0.57 | |
Sales general and administrative to revenue | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.13 | -0.04 | -0.02 | -0.02 | -0.01 | |
Capex to revenue | -0.03 | -0.02 | -0.01 | -0.01 | 0 | |
Capex to depreciation | -7.41 | -2.61 | -1.45 | -1.04 | -0.58 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 10.11 | 25.75 | 25.24 | 26.22 | 19.94 | |
ROIC | 0.04 | 0.11 | 0.08 | 0.08 | 0.08 | |
Return on tangible assets | 0 | 0.02 | 0.01 | 0.01 | 0.01 | |
Graham Net | -70.41 | -77.44 | -88.63 | -102.8 | -103.99 | |
Working capital | 892.74B | 1075.48B | 1234.51B | 1453.27B | 1824.58B | |
Tangible asset value | 315.38B | 401.51B | 448.88B | 478.65B | 437.03B | |
Net current asset value | 1983.64B | 2183.47B | 2498.89B | 2894.34B | 2921.47B | |
Invested capital | 0.06 | 0.15 | 0.13 | 0.12 | 0.11 | |
Average receivables | 28.44B | 23.89B | 23.01B | 22.36B | 20.03B | |
Average payables | 52.61B | 56.59B | 60.26B | 59.45B | 58.82B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 15.2 | 10.84 | 11.04 | 9.01 | 8.94 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 24.01 | 33.68 | 33.05 | 40.5 | 40.82 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.04 | 0.14 | 0.11 | 0.11 | 0.07 | |
Capex per share | -0.69 | -0.4 | -0.26 | -0.19 | -0.11 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.56 | 3.67 | 13.12 | 2.54 | 18.47 | |
Net income per share | 0.2 | 0.03 | 0.64 | 0.31 | -0.69 | |
Operating cash flow per share | 1.64 | 2.24 | 6.17 | 3.04 | 3.13 | |
Free cash flow per share | -1.67 | 2.19 | 6.15 | 3.03 | -0.58 | |
Cash per share | 61.78 | 66.17 | 72.11 | 101.98 | 76.52 | |
Book value per share | 16.15 | 15.47 | 16.52 | 16.91 | 15.35 | |
Tangible book value per share | 16.16 | 15.5 | 16.55 | 192.84 | 15.4 | |
Share holders equity per share | 16.15 | 15.47 | 16.52 | 16.91 | 15.35 | |
Interest debt per share | 2.01 | 1.75 | 3.27 | 0.3 | 0.48 | |
Market cap | 256.06B | 333.65B | 314.72B | 341.12B | 327.18B | |
Enterprise value | 191.25B | 255.4B | 365.3B | 194.24B | 182.46B | |
P/E ratio | 11.41 | 86.44 | 4.4 | 9.69 | -4.1 | |
Price to sales ratio | 1.39 | 3.23 | 0.86 | 4.76 | 0.62 | |
POCF ratio | 5.55 | 5.28 | 1.83 | 3.97 | 3.64 | |
PFCF ratio | -5.44 | 5.4 | 1.83 | 3.99 | -19.47 | |
P/B Ratio | 0.56 | 0.76 | 0.68 | 0.71 | 0.74 | |
PTB ratio | 0.56 | 0.76 | 0.68 | 0.71 | 0.74 | |
EV to sales | 1.04 | 2.47 | 1 | 2.71 | 0.34 | |
Enterprise value over EBITDA | -8.32K | -38.27 | 19.41 | 130.71 | -5.23 | |
EV to operating cash flow | 4.14 | 4.05 | 2.12 | 2.26 | 2.03 | |
EV to free cash flow | -4.07 | 4.13 | 2.13 | 2.27 | -10.86 | |
Earnings yield | 0.02 | 0 | 0.06 | 0.03 | -0.06 | |
Free cash flow yield | -0.18 | 0.19 | 0.55 | 0.25 | -0.05 | |
Debt to equity | 0.12 | 0.11 | 0.11 | 0.1 | 0.03 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Net debt to EBITDA | 2.82K | 11.73 | 2.69 | -98.85 | 4.15 | |
Current ratio | 27.49 | 31 | 29.04 | 41.75 | 32.32 | |
Interest coverage | 0 | 0 | 1.45 | -0.04 | 0 | |
Income quality | 8.14 | 65.43 | 21.32 | 10.64 | 1.7K | |
Dividend Yield | 0.1 | 0.02 | 0.01 | 0 | 0.06 | |
Payout ratio | 4.36 | 6.28 | 0.19 | 0.18 | -1.01 | |
Sales general and administrative to revenue | 0.05 | 0.12 | 0.03 | 0.14 | 0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -2.02 | -0.02 | 0 | -0.01 | -1.19 | |
Capex to revenue | -0.51 | -0.01 | 0 | -0.01 | -0.2 | |
Capex to depreciation | 37 | -0.28 | -0.61 | -0.37 | 44.88 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 8.52 | 3.45 | 15.43 | 10.89 | 15.47 | |
ROIC | 0 | 0 | 0.11 | 0 | -0.05 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | -104.37 | -103.79 | -103.51 | 100.9 | -104.43 | |
Working capital | 1671.89B | 1824.58B | 2060.64B | 2813.42B | 2263.38B | |
Tangible asset value | 453.72B | 437.03B | 461.83B | 5450.47B | 443.13B | |
Net current asset value | 2930.96B | 2921.47B | 2858.18B | 2834.12B | 2972.25B | |
Invested capital | 0.12 | 0.11 | 0.11 | 0.1 | 0.03 | |
Average receivables | 25.11B | 9.85B | 70.78B | 72.71B | 78.41B | |
Average payables | 61.02B | 61.26B | 67.15B | 71.26B | 70.66B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 17.14 | 29.95 | 29.58 | 22.56 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 5.25 | 3.01 | 3.04 | 3.99 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.01 | 0 | 0.04 | 0.02 | -0.05 | |
Capex per share | -3.32 | -0.05 | -0.03 | -0.02 | -3.71 |
2628.HK Frequently Asked Questions
What is China Life Insurance Company Limited stock symbol ?
China Life Insurance Company Limited is a CN stock and trading under the symbol 2628.HK
What is China Life Insurance Company Limited stock quote today ?
China Life Insurance Company Limited stock price is $9.39 today.
Is China Life Insurance Company Limited stock public?
Yes, China Life Insurance Company Limited is a publicly traded company.